Form 4 Tracker
Flemming Steen Jensen

EVP & Product Supply and Quality · 1 filing · Latest: May 11, 2026

Ascendis Pharma A/S
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ASND
Flemming Steen JensenEVP & Product Supply and QualityMay 11, 2026
Sale
$238.4919,460$4.6M0
ASND
JENSEN FLEMMING STEENMay 11, 2026
Proposed Sale
$238.4919,460$4.6M
ASND
JENSEN FLEMMING STEENMar 2, 2026
Proposed Sale
$242.0910,800$2.6M
ASND
JENSEN FLEMMING STEENDec 2, 2025
Proposed Sale
$205.8510,000$2.1M
ASND
JENSEN FLEMMING STEENSep 9, 2025
Proposed Sale
$203.705,000$1.0M
ASND
JENSEN FLEMMING STEENAug 13, 2025
Proposed Sale
$191.3210,000$1.9M
ASND
JENSEN FLEMMING STEENMay 7, 2025
Proposed Sale
$162.2010,938$1.8M
ASND
JENSEN FLEMMING STEENMar 6, 2025
Proposed Sale
$152.3910,000$1.5M
ASND
JENSEN FLEMMING STEENMar 4, 2025
Proposed Sale
$152.127,719$1.2M
ASND
JENSEN FLEMMING STEENFeb 18, 2025
Proposed Sale
$146.8010,000$1.5M
ASND
JENSEN FLEMMING STEENDec 10, 2024
Proposed Sale
$129.131,222$157.8K
ASND
JENSEN FLEMMING STEENDec 3, 2024
Proposed Sale
$131.379,375$1.2M